We are live on ! Find out more
GNMX

Corgi Genomics & Precision Medicine ETF
GNMX

1 hedge funds and large institutions have $387K invested in Corgi Genomics & Precision Medicine ETF in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22.61% more ownership

Funds ownership: 0% → 22.61% (+23%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GS
GTS Securities
Florida
+$331K

Top Sellers

No sellers this quarter

GNMX Hedge Fund Activity: Q2 2026 in Review

1 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in Corgi Genomics & Precision Medicine ETF (GNMX) for Q2 2026, worth a combined $387K.

Buyers outnumbered sellers: 1 fund opened new GNMX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was GTS Securities, opening a new position worth an estimated $331K.

  • 1 institutional investor held Corgi Genomics & Precision Medicine ETF (GNMX) as of Q2 2026, up from 0 in Q1 2026.
  • Funds reported $387K of Corgi Genomics & Precision Medicine ETF stock for Q2 2026.
  • 1 fund opened new Corgi Genomics & Precision Medicine ETF positions in Q2 2026 and 0 closed out, a net change of +1 holder.
  • The largest Corgi Genomics & Precision Medicine ETF buyer in Q2 2026 was GTS Securities, an estimated $331K added.

Based on aggregated 13F filings for Q2 2026.